Georgia Tech: Open Source Machine Learning Tool Could Help Choose Cancer Drugs

Georgia Tech: Open Source Machine Learning Tool Could Help Choose Cancer Drugs. “The selection of a first-line chemotherapy drug to treat many types of cancer is often a clear-cut decision governed by standard-of-care protocols, but what drug should be used next if the first one fails? That’s where Georgia Institute of Technology researchers believe their new open source decision support tool could come in. Using machine learning to analyze RNA expression tied to information about patient outcomes with specific drugs, the open source tool could help clinicians chose the chemotherapy drug most likely to attack the disease in individual patients.”

New York Times: Top Cancer Researcher Fails to Disclose Corporate Financial Ties in Major Research Journals

New York Times: Top Cancer Researcher Fails to Disclose Corporate Financial Ties in Major Research Journals. “One of the world’s top breast cancer doctors failed to disclose millions of dollars in payments from drug and health care companies in recent years, omitting his financial ties from dozens of research articles in prestigious publications like The New England Journal of Medicine and The Lancet.”

STAT News: IBM’s Watson supercomputer recommended ‘unsafe and incorrect’ cancer treatments, internal documents show

STAT News: IBM’s Watson supercomputer recommended ‘unsafe and incorrect’ cancer treatments, internal documents show. This article is paywalled. “Internal IBM documents show that its Watson supercomputer often spit out erroneous cancer treatment advice and that company medical specialists and customers identified ‘multiple examples of unsafe and incorrect treatment recommendations’ as IBM was promoting the product to hospitals and physicians around the world.”

XinhuaNet: Chinese scientists establish database to improve radiotherapy

XinhuaNet: Chinese scientists establish database to improve radiotherapy. “Chinese scientists have established an online database to help improve radiotherapy efficacy and clinical treatment of cancer. The Cancer Radiosensitivity Regulation Factors Database was jointly developed by Hefei Institute of Physical Science under the Chinese Academy of Sciences and Anhui University. It provides information on genes, drugs, as well as other regulators that affect the radiosensitivity of each specific cancer.”

OHS: New IARC Website Tracks UV Radiation Cancers

OHS: New IARC Website Tracks UV Radiation Cancers. “The International Agency for Research on Cancer (IARC) recently launched its new database on cancers attributable to ultraviolet (UV) radiation. Part of the Global Cancer Observatory, the website aims to provide estimates of the preventable melanoma burden using a standardized analytical approach for all countries.”

New Scientist: Global cancer scheme lets people share data across the world

New Scientist: Global cancer scheme lets people share data across the world. “People with cancer will soon be able to donate their medical information to a global database aimed at discovering new treatments…. When the database becomes fully functional later this year, any individual with cancer will have access to a document – the ‘Universal Patient Consent Form’ – that will allow them to make their medical and genetic data freely accessible to all cancer researchers.”

PR Newswire: NCCN Provides New, Free Database to Assist in Cancer Research Collaborations

PR Newswire: NCCN Provides New, Free Database to Assist in Cancer Research Collaborations (PRESS RELEASE). “The National Comprehensive Cancer Network® (NCCN®) Oncology Research Program (ORP) announced today that they are broadening the use of the Shared Resource Database to all cancer centers in the United States. This move reinforces NCCN ORP’s dedication to collaborative research that improves cancer care…. The Shared Resource Database currently includes more than 240 resources, such as complex technologies, instrumentation facilities, human tissue specimens, animal models, specialized databases, and many other specialty research items. It has been available exclusively to the 27 NCCN Member Institutions for the past two years.”